Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 267

1.

Recruitment of CD34(+) fibroblasts in tumor-associated reactive stroma: the reactive microvasculature hypothesis.

San Martin R, Barron DA, Tuxhorn JA, Ressler SJ, Hayward SW, Shen X, Laucirica R, Wheeler TM, Gutierrez C, Ayala GE, Ittmann M, Rowley DR.

Am J Pathol. 2014 Jun;184(6):1860-70. doi: 10.1016/j.ajpath.2014.02.021. Epub 2014 Apr 5.

PMID:
24713391
[PubMed - in process]
2.

Splicing biomarkers of disease severity in myotonic dystrophy.

Nakamori M, Sobczak K, Puwanant A, Welle S, Eichinger K, Pandya S, Dekdebrun J, Heatwole CR, McDermott MP, Chen T, Cline M, Tawil R, Osborne RJ, Wheeler TM, Swanson MS, Moxley RT 3rd, Thornton CA.

Ann Neurol. 2013 Dec;74(6):862-72. doi: 10.1002/ana.23992.

PMID:
23929620
[PubMed - indexed for MEDLINE]
3.

Metabolomic signatures of aggressive prostate cancer.

McDunn JE, Li Z, Adam KP, Neri BP, Wolfert RL, Milburn MV, Lotan Y, Wheeler TM.

Prostate. 2013 Oct;73(14):1547-60. doi: 10.1002/pros.22704. Epub 2013 Jul 3.

PMID:
23824564
[PubMed - indexed for MEDLINE]
Free Article
4.

HLA-restricted NY-ESO-1 peptide immunotherapy for metastatic castration resistant prostate cancer.

Sonpavde G, Wang M, Peterson LE, Wang HY, Joe T, Mims MP, Kadmon D, Ittmann MM, Wheeler TM, Gee AP, Wang RF, Hayes TG.

Invest New Drugs. 2014 Apr;32(2):235-42. doi: 10.1007/s10637-013-9960-9. Epub 2013 Apr 23.

PMID:
23609828
[PubMed - in process]
5.

Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing.

Bjurlin MA, Carter HB, Schellhammer P, Cookson MS, Gomella LG, Troyer D, Wheeler TM, Schlossberg S, Penson DF, Taneja SS.

J Urol. 2013 Jun;189(6):2039-46. doi: 10.1016/j.juro.2013.02.072. Epub 2013 Feb 26. Review.

PMID:
23485507
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Development and clinical validation of a real-time PCR assay for PITX2 DNA methylation to predict prostate-specific antigen recurrence in prostate cancer patients following radical prostatectomy.

Dietrich D, Hasinger O, Bañez LL, Sun L, van Leenders GJ, Wheeler TM, Bangma CH, Wernert N, Perner S, Freedland SJ, Corman JM, Ittmann MM, Lark AL, Madden JF, Hartmann A, Schatz P, Kristiansen G.

J Mol Diagn. 2013 Mar;15(2):270-9. doi: 10.1016/j.jmoldx.2012.11.002. Epub 2012 Dec 22.

PMID:
23266319
[PubMed - indexed for MEDLINE]
7.

Dataset for reporting of prostate carcinoma in radical prostatectomy specimens: recommendations from the International Collaboration on Cancer Reporting.

Kench JG, Delahunt B, Griffiths DF, Humphrey PA, McGowan T, Trpkov K, Varma M, Wheeler TM, Srigley JR.

Histopathology. 2013 Jan;62(2):203-18. doi: 10.1111/his.12042. Review.

PMID:
23240714
[PubMed - indexed for MEDLINE]
8.

RNA interference targeting CUG repeats in a mouse model of myotonic dystrophy.

Sobczak K, Wheeler TM, Wang W, Thornton CA.

Mol Ther. 2013 Feb;21(2):380-7. doi: 10.1038/mt.2012.222. Epub 2012 Nov 27.

PMID:
23183533
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Intraductal carcinoma of the prostate: precursor or aggressive phenotype of prostate cancer?

Bonkhoff H, Wheeler TM, van der Kwast TH, Magi-Galluzzi C, Montironi R, Cohen RJ.

Prostate. 2013 Mar;73(4):442-8. doi: 10.1002/pros.22579. Epub 2012 Sep 4. Review.

PMID:
22949099
[PubMed - indexed for MEDLINE]
10.

Targeting nuclear RNA for in vivo correction of myotonic dystrophy.

Wheeler TM, Leger AJ, Pandey SK, MacLeod AR, Nakamori M, Cheng SH, Wentworth BM, Bennett CF, Thornton CA.

Nature. 2012 Aug 2;488(7409):111-5. doi: 10.1038/nature11362.

PMID:
22859208
[PubMed - indexed for MEDLINE]
11.

Do adenocarcinomas of the prostate with Gleason score (GS) ≤6 have the potential to metastasize to lymph nodes?

Ross HM, Kryvenko ON, Cowan JE, Simko JP, Wheeler TM, Epstein JI.

Am J Surg Pathol. 2012 Sep;36(9):1346-52. doi: 10.1097/PAS.0b013e3182556dcd.

PMID:
22531173
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Pseudolumen size and perimeter in prostate cancer: correlation with patient outcome.

Iczkowski KA, Torkko KC, Kotnis GR, Wilson RS, Huang W, Wheeler TM, Abeyta AM, Lucia MS.

Prostate Cancer. 2011;2011:693853. doi: 10.1155/2011/693853. Epub 2011 Jul 14.

PMID:
22110997
[PubMed]
Free PMC Article
13.

Progressive myopathy in an inducible mouse model of oculopharyngeal muscular dystrophy.

Mankodi A, Wheeler TM, Shetty R, Salceies KM, Becher MW, Thornton CA.

Neurobiol Dis. 2012 Jan;45(1):539-46. doi: 10.1016/j.nbd.2011.09.010. Epub 2011 Sep 21.

PMID:
21964252
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

GLIPR1 tumor suppressor gene expressed by adenoviral vector as neoadjuvant intraprostatic injection for localized intermediate or high-risk prostate cancer preceding radical prostatectomy.

Sonpavde G, Thompson TC, Jain RK, Ayala GE, Kurosaka S, Edamura K, Tabata K, Ren C, Goltsov AA, Mims MP, Hayes TG, Ittmann MM, Wheeler TM, Gee A, Miles BJ, Kadmon D.

Clin Cancer Res. 2011 Nov 15;17(22):7174-82. doi: 10.1158/1078-0432.CCR-11-1899. Epub 2011 Sep 20.

PMID:
21933889
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Digital quantification of five high-grade prostate cancer patterns, including the cribriform pattern, and their association with adverse outcome.

Iczkowski KA, Torkko KC, Kotnis GR, Wilson RS, Huang W, Wheeler TM, Abeyta AM, La Rosa FG, Cook S, Werahera PN, Lucia MS.

Am J Clin Pathol. 2011 Jul;136(1):98-107. doi: 10.1309/AJCPZ7WBU9YXSJPE.

PMID:
21685037
[PubMed - indexed for MEDLINE]
Free Article
16.

Understanding the pathological features of focality, grade and tumour volume of early-stage prostate cancer as a foundation for parenchyma-sparing prostate cancer therapies: active surveillance and focal targeted therapy.

Mouraviev V, Villers A, Bostwick DG, Wheeler TM, Montironi R, Polascik TJ.

BJU Int. 2011 Oct;108(7):1074-85. doi: 10.1111/j.1464-410X.2010.10039.x. Epub 2011 Apr 13. Review.

PMID:
21489116
[PubMed - indexed for MEDLINE]
17.

Desquamating apoptotic variant of high-grade prostatic intraepithelial neoplasia: a possible precursor of intraductal prostatic carcinoma.

Cohen RJ, O'Brien BA, Wheeler TM.

Hum Pathol. 2011 Jun;42(6):892-5. doi: 10.1016/j.humpath.2010.09.008. Epub 2011 Feb 1.

PMID:
21288556
[PubMed - indexed for MEDLINE]
18.

Ductal adenocarcinoma of the prostate.

Cohen RJ, O'Brien BA, Wheeler TM.

Hum Pathol. 2011 Apr;42(4):605-6; author reply 606-7. doi: 10.1016/j.humpath.2010.07.025. Epub 2011 Jan 15. No abstract available.

PMID:
21237485
[PubMed - indexed for MEDLINE]
19.

Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens.

Ayala GE, Muezzinoglu B, Hammerich KH, Frolov A, Liu H, Scardino PT, Li R, Sayeeduddin M, Ittmann MM, Kadmon D, Miles BJ, Wheeler TM, Rowley DR.

Am J Pathol. 2011 Jan;178(1):79-87. doi: 10.1016/j.ajpath.2010.09.042. Epub 2010 Dec 23.

PMID:
21224046
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 1: specimen handling.

Samaratunga H, Montironi R, True L, Epstein JI, Griffiths DF, Humphrey PA, van der Kwast T, Wheeler TM, Srigley JR, Delahunt B, Egevad L; ISUP Prostate Cancer Group.

Mod Pathol. 2011 Jan;24(1):6-15. doi: 10.1038/modpathol.2010.178. Epub 2010 Sep 10. Review.

PMID:
20834234
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk